JOHN BELMONT to Genetic Therapy
This is a "connection" page, showing publications JOHN BELMONT has written about Genetic Therapy.
Connection Strength
0.122
-
Expression vectors for human adenosine deaminase gene therapy. Genome. 1989; 31(2):832-9.
Score: 0.058
-
Delivery of a secretable adenosine deaminase through microcapsules--a novel approach to somatic gene therapy. Hum Gene Ther. 1994 Dec; 5(12):1445-55.
Score: 0.022
-
Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood. 1992 Mar 15; 79(6):1393-9.
Score: 0.018
-
Gene therapy: a new approach for the treatment of genetic disorders. Clin Pharmacol Ther. 1990 Jan; 47(1):1-11.
Score: 0.015
-
Expression of human CD18 in murine granulocytes and improved efficiency for infection of deficient human lymphoblasts. Hum Gene Ther. 1993 Feb; 4(1):25-34.
Score: 0.005
-
Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells. Hum Gene Ther. 1991; 2(3):203-13.
Score: 0.004